Search results
Showing 136 to 150 of 1251 results for public health guidance
In development Reference number: GID-TA11819 Expected publication date: 03 September 2026
In development Reference number: GID-TA10143 Expected publication date: TBC
In development Reference number: GID-HTE10011 Expected publication date: TBC
In development Reference number: GID-TA11576 Expected publication date: 18 June 2026
Aficamten for treating symptomatic obstructive hypertrophic cardiomyopathy [ID6575]
In development Reference number: GID-TA11742 Expected publication date: 29 July 2026
In development Reference number: GID-TA11802 Expected publication date: TBC
This quality standard covers sexual health, focusing on preventing sexually transmitted infections (STIs). It describes high-quality care in priority areas for improvement.
View quality statements for QS178Show all sections
Sections for QS178
- Quality statements
- Quality statement 1: Asking people about their sexual history
- Quality statement 2: Discussing prevention and testing with people who are at risk of sexually transmitted infections
- Quality statement 3: Condom distribution schemes
- Quality statement 4: Access to sexual health services
- Quality statement 5: Repeat testing for sexually transmitted infections
- Quality statement 6: Partner notification
- Update information
This guideline covers targeted interventions to prevent misuse of drugs, including illegal drugs, ‘legal highs’ and prescription-only medicines. It aims to prevent or delay harmful use of drugs in children, young people and adults who are most likely to start using drugs or who are already experimenting or using drugs occasionally.
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps [ID6379]
In development Reference number: GID-TA11429 Expected publication date: 09 September 2026
Deferred Reference number: GID-TA11531
In development Reference number: GID-TA10990 Expected publication date: TBC
In development Reference number: GID-TA11772 Expected publication date: 03 September 2026
Appraisal is the process of determining which records have continuing business or historical value from those which have no further value and should be disposed of appropriately.
In development Reference number: GID-TA11774 Expected publication date: 30 September 2026
Olezarsen for treating familial chylomicronaemia syndrome [ID6585]
In development Reference number: GID-TA11678 Expected publication date: 19 August 2026